These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 14967459)

  • 21. Heterogeneity of tumour response to combined radiotherapy and EGFR inhibitors: differences between antibodies and TK inhibitors.
    Krause M; Gurtner K; Deuse Y; Baumann M
    Int J Radiat Biol; 2009 Nov; 85(11):943-54. PubMed ID: 19895271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Biomodulation and radiotherapy].
    Bourhis J; Lartigau E
    Cancer Radiother; 2000 Nov; 4 Suppl 1():128s-133s. PubMed ID: 11194950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction of EGFR with the tumour microenvironment: implications for radiation treatment.
    Nijkamp MM; Span PN; Bussink J; Kaanders JH
    Radiother Oncol; 2013 Jul; 108(1):17-23. PubMed ID: 23746695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The problems of combining chemotherapy and radiotherapy].
    Tanaka Y; Hasegawa T; Akagi K; Kato T
    Gan No Rinsho; 1987 Oct; 33(13):1664-72. PubMed ID: 3694800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Tolerance dosage of normal tissues by radiotherapy combined with chemotherapy in the group of patients].
    Hishikawa Y
    Gan No Rinsho; 1990 Oct; 36(13):2353-6. PubMed ID: 2250356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacological consequences of the targeting of epidermal growth factor receptor].
    Milano G; Magné N
    Bull Cancer; 2003 Nov; 90 Spec No():S197-201. PubMed ID: 14763140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Targeted therapies and radiotherapy].
    Hennequin C; Giocanti N; Favaudon V
    Bull Cancer; 2005 Dec; 92(12):1085-92. PubMed ID: 16396755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integration of EGFR inhibitors with radiochemotherapy.
    Nyati MK; Morgan MA; Feng FY; Lawrence TS
    Nat Rev Cancer; 2006 Nov; 6(11):876-85. PubMed ID: 17036041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Should we be surprised at the paucity of response to EGFR inhibitors?
    Gusterson BA; Hunter KD
    Lancet Oncol; 2009 May; 10(5):522-7. PubMed ID: 19410197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidermal growth factor receptor modulation of radiation response: preclinical and clinical development.
    Harari PM; Huang SM
    Semin Radiat Oncol; 2002 Jul; 12(3 Suppl 2):21-6. PubMed ID: 12174341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [New strategies to interfere with radiation response: "biomodulation" of radiation therapy].
    Deutsch E; Kaliski A; Maggiorella L; Bourhis J
    Cancer Radiother; 2005 Mar; 9(2):69-76. PubMed ID: 15820434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The future of cytotoxic therapy: selective cytotoxicity based on biology is the key.
    de Bono JS; Tolcher AW; Rowinsky EK
    Breast Cancer Res; 2003; 5(3):154-9. PubMed ID: 12793897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of chemoprotectants in chemotherapy and radiation therapy: the challenges of selecting an appropriate agent.
    Jena G; Vikram A; Tripathi DN; Ramarao P
    Integr Cancer Ther; 2010 Sep; 9(3):253-8. PubMed ID: 20702492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular targets for radiation therapy: bringing preclinical data into clinical trials.
    Tofilon PJ; Saxman S; Coleman CN
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3518-20. PubMed ID: 14506136
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical significance of cellular resistance in tumours to cytotoxic chemotherapy and radiotherapy.
    Pomeroy M; Moriarty M
    Cytotechnology; 1993; 12(1-3):385-91. PubMed ID: 7764459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic agents for treatment of established metastases and inhibitors of metastatic spread: preclinical and clinical progress.
    Goldfarb RH; Brunson KW
    Curr Opin Oncol; 1992 Dec; 4(6):1130-41. PubMed ID: 1281001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Biologic problems of combined antineoplastic radiotherapy and chemotherapy].
    Bergonzini R; Torricelli A
    Minerva Radiol; 1965 Jun; 10(6):267-72. PubMed ID: 5841917
    [No Abstract]   [Full Text] [Related]  

  • 38. [Association of radiotherapy and chemotherapy in the treatment of epithelial neoplasms. Methodological and clinical observations in 129 cases].
    Bergonzini R; Ferolla G; Pasquinelli G; Morini M
    Minerva Radiol; 1967 Dec; 12(12):544-54. PubMed ID: 5607072
    [No Abstract]   [Full Text] [Related]  

  • 39. Combining radiation and molecular targeting in cancer therapy.
    Camphausen K; Tofilon PJ
    Cancer Biol Ther; 2004 Mar; 3(3):247-50. PubMed ID: 15107611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of radiation therapy with molecular targeted agents.
    Morris ZS; Harari PM
    J Clin Oncol; 2014 Sep; 32(26):2886-93. PubMed ID: 25113770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.